Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

Added 395 days ago (28.04.2021)
Authors: Arne Kolstad; Lone Bredo Pedersen; Christian W Eskelund; Simon Husby; Kirsten Grønbæk; Mats Jerkeman; Anna Laurell; Riikka Räty; Erkki Elonen; Niels Smedegaard Andersen; Peter deNully Brown; Eva Kimby; Hans Bentzen; Christer Sundström; Mats Ehinger; Marja-Liisa Karjalainen-Lindsberg; Jan Delabie; Elisabeth Ralfkiær; Unn-Merete Fagerli; Herman Nilsson-Ehle; Grete Fossum Lauritzsen; Outi Kuittinen; Carsten Niemann; Christian Hartman Geisler; Nordic Lymphoma Group
Read article